Price$5.60+0.69 (+14.17%)
2026-03-042026-06-05
News · 26 weeks52-43%
2025-12-142026-06-07
Mix4290d
- Insider26(62%)
- SEC Filings9(21%)
- Other5(12%)
- Earnings1(2%)
- Dividends1(2%)
Latest news
25 items- SECSEC Form 6-K filed by ICL Group Ltd.6-K - ICL Group Ltd. (0000941221) (Filer)
- INSIDERSEC Form 3 filed by new insider Kilstein Alegra3 - ICL Group Ltd. (0000941221) (Issuer)
- SECSEC Form 6-K filed by ICL Group Ltd.6-K - ICL Group Ltd. (0000941221) (Filer)
- PRICL Group Announces Launch of Senior Notes OfferingICL Group Ltd. (NYSE & TASE: ICL) (the "Company" or "ICL") hereby announces that it has commenced an offering (the "Offering") of new unsecured senior notes (the "Notes"), the amount and terms of which have yet to be determined. The Company intends to use the net proceeds from the Offering for general corporate purposes, including the repayment, in part or in full, of outstanding borrowings under its revolving credit facility which matures in April 2030 (the "Revolving Credit Facility") (following such repayment, the Revolving Credit Facility will remain available to ICL in accordance with its terms), the repayment of other debt, capital expenditures, investments and acquisitions, supportin
- SECSEC Form 6-K filed by ICL Group Ltd.6-K - ICL Group Ltd. (0000941221) (Filer)
- SECSEC Form 6-K filed by ICL Group Ltd.6-K - ICL Group Ltd. (0000941221) (Filer)
- SECSEC Form 6-K filed by ICL Group Ltd.6-K - ICL Group Ltd. (0000941221) (Filer)
- PRICL Reports First Quarter 2026 Results- Following a strong quarter, company increases full year EBITDA guidance to $1.5 billion to $1.7 billion - - Company continuing to execute against strategy to accelerate growth in specialty crop nutrition and specialty food solutions - - Sales of $2.0 billion increased 14% year-over-year, with operating income of $235 million up 27%, adjusted net income of $139 million up 26%, adjusted EBITDA of $412 million up 15% and adjusted diluted EPS of $0.11 up 22% - ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2026. Consolidated sales of $2.0 billion were up 14% versus $1.8 billion in the prior
- SECSEC Form 6-K filed by ICL Group Ltd.6-K - ICL Group Ltd. (0000941221) (Filer)
- SECSEC Form 6-K filed by ICL Group Ltd.6-K - ICL Group Ltd. (0000941221) (Filer)
- PRICL Announces First Quarter 2026 Earnings CallICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2026 results prior to the opening of the TASE market on Wednesday, May 13, 2026. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (833) 461-5787, or (585) 542-9983 for international analysts, and the conference ID is 273801307. To participate, please dial in a few minutes before the scheduled time.
- INSIDERSEC Form 3 filed by new insider Perelman Uri3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Doppelt Yoav3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Kabalek Yaniv3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ilani Nir3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Mishor Miriam3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Grinfeld Maya3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Geva Harel Lilach3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Fahima Ilana3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Aharonson Elad3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lahav Aviram3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Desikan Anantha3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Meshulam Amir3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Silverberg Michal3 - ICL Group Ltd. (0000941221) (Issuer)
- INSIDERSEC Form 3 filed by new insider Turner Nadav3 - ICL Group Ltd. (0000941221) (Issuer)
ICL FAQ
8 questionsWhat does ICL Group Ltd. do?
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment extracts...Where does ICL stock trade?
ICL Group Ltd. (ICL) is listed on NYSE.What sector and industry is ICL in?
ICL Group Ltd. operates in the Industrials sector, Agricultural Chemicals industry.When did ICL Group Ltd. go public?
ICL Group Ltd. (ICL) completed its IPO in 2014.Does ICL pay a dividend?
ICL's most recent ex-dividend date was 2026-06-02 with a cash dividend of $0.05 per share. No future ex-date is on file yet.What are analysts saying about ICL?
ICL Group Ltd. has had 7 recent analyst actions on file. The most recent action was from Barclays: Equal Weight with a $600.00 price target on 2025-01-21. Recent price targets range from $400.00 to $1200.00.What companies are similar to ICL?
Notable peers in the same industry include NTR (Nutrien Ltd.), CF (CF Industries Holdings Inc.), MOS (Mosaic Company), SMG (Scotts Miracle-Gro Company), UAN (CVR Partners LP). Compare ICL side-by-side with any of them on Quantisnow.How can I track ICL on Quantisnow?
Quantisnow aggregates ICL Group Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ICL to receive live email and push alerts on every new disclosure.